New heart valve procedure aimed at High-Risk patients, but study never started
NCT ID NCT03714412
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study planned to test a new device called the Cardiovalve, which is placed through a leg vein to replace a leaky mitral heart valve without open-chest surgery. It was designed for people with severe mitral regurgitation who were too high-risk for traditional surgery. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hygeia Hospital
Athens, Greece
-
Silesian Center for Heart Diseases
Zabrze, 41-800, Poland
Conditions
Explore the condition pages connected to this study.